Quantitation of response to therapy in calcium urolithiasis
- PMID: 388797
- DOI: 10.1007/BF00257207
Quantitation of response to therapy in calcium urolithiasis
Abstract
The physico-chemical basis for the action of various drugs in calcium nephrolithiasis may be described in terms of changes produced in the urinary state of saturation (APR), limit of metastability (FPR), or in crystal growth. The validation of this scheme for drug action requires further correlation of objective responses to drug therapy, described in terms of urinary crystallisation, with the clinical response.
Similar articles
-
Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.Metabolism. 1977 Feb;26(2):201-5. doi: 10.1016/0026-0495(77)90056-7. Metabolism. 1977. PMID: 834153
-
Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.J Urol. 1978 Oct;120(4):399-401. doi: 10.1016/s0022-5347(17)57198-0. J Urol. 1978. PMID: 702659
-
Management of the stone former.Semin Urol. 1984 Feb;2(1):34-44. Semin Urol. 1984. PMID: 6463460 No abstract available.
-
[Effect of orthophosphate, pyrophosphate and diphosphonate in urinary-calculi metaphylaxis].Z Urol Nephrol. 1977 Jun;70(6):449-52. Z Urol Nephrol. 1977. PMID: 198996 Review. German. No abstract available.
-
Calcium oxalate renal stones.Annu Rev Med. 1975;26:173-9. doi: 10.1146/annurev.me.26.020175.001133. Annu Rev Med. 1975. PMID: 1096755 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous